Clinical Trials - Tiếng anh chuyên ngành | Trường đại học Quốc Tế Hồng Bàng

Clinical Trials - Tiếng anh chuyên ngành | Trường đại học Quốc Tế Hồng Bàng  được sưu tầm và soạn thảo dưới dạng file PDF để gửi tới các bạn sinh viên cùng tham khảo, ôn tập đầy đủ kiến thức, chuẩn bị cho các buổi học thật tốt. Mời bạn đọc đón xem!

28 14 lượt tải Tải xuống
Chia sẻ Báo cáo tài liệu

Môn: Tiếng anh chuyên ngành(TACN34)

Trường: Đại Học Quốc Tế Hồng Bàng

Thông tin:

3 trang 5 tháng trước

Tác giả:

Profile Nguyễn Vân
19112023 - CLINICAL TRIALS
1. Which phase includes participants with the disease the product could treat potentially?
A. Phase 1 B. Phase 2 C. Phase 3 D. Phase 4
2. Which factor below decides most the success of a clinical trial?
A. Laboratory B. Finance C. Length D. Volunteers’ participation
3. Which of these is NOT a function of FDA?
A. Creating guidelines for the approval & use of drugs.
B. Requiring that all approved drugs fulfill 2 standards.
C. Be responsible for the safety regulation of most types of drugs.
D. Testing drugs through 4 phases of clinical trials before they can be sold to individuals.
4. How long is the pre-clinical development stage?
A. 1 year B. 1-2 years C. 3-4 years D. 4-5 years
5. Which statement is INCORRECT?
A. Only 1 or 2 medicines gets approval for use on prescription.
B. Lisinopril treats hypertension. C. Phase 3 is the longest of the 3 phases.
D. All medicines used today must undergo chemical processes.
6. Which phase finds the most suitable dose?
A. Phase 1 B. Phase 2 C. Phase 3 D. Phase 4
7. There is a trend for in vitro and human volunteer protocols animal tests
where possible.
A. continuing – tested - to replace
B. to continuing – testing - to replace
C. continuing – testing - to be replaced
D. continuing – testing - to replace
8. Which phase includes participants with the disease the product could treat potentially?
A. Phase 1 B. Phase 2 C. Phase 3 D. Phase 4
9. Which factor below decides most the success of a clinical trial?
A. Laboratory B. Finance C. Length D. Volunteers’ participation
10. Which of these is NOT a function of FDA?
A. Creating guidelines for the approval & use of drugs.
B. Requiring that all approved drugs fulfill 2 standards.
C. Be responsible for the safety regulation of most types of drugs.
D. Testing drugs through 4 phases of clinical trials before they can be sold to individuals.
1
11. Which definition below refers to “placebo”?
A. With active ingredients
B. With inactive ingredients
C. With inactive ingredients w treatment value
D. With inactive ingredients, no medicinal value
12. Which information is IN CORRECT about blinding feature?
A. The identification related to participants will be revealed at the end of the trial.
B. Single-blinding means participants know well about the treatment they are receiving.
C. Thanks to blinding, bias does not affect the trial or the interpretation of its results.
D. A double-blinded trial means that neither the team nor the participants know each other well.
13. Clinical trials are generally not a __________ for patients to receive long-term treatment for their
chronic disease still clinical trials often represent an option to be seriously __________.
A. means/ take into consideration B. means/ considered
C. means/ into considering D. mean/ taken into consideration
14. Which information below is INCORRECT?
A. Drugs are tested before going on market.
B. Drugs are tested on animals first and later on humans.
C. Participants do not know which treatment they are treating.
D. It takes a small amount of money and lots of time to have one clinical trial.
15. The participants found __________ – and who agree __________ – are given specific instructions,
and then monitor and carefully __________ during the trial and after it is completed.
A. eligible/ to participate/ assessed B. eligibly/ to participate/ assessed
C. eligible/ participate/ assessing D. eligibly/ participate/ assessing
2
3
| 1/3
| | Tải xuống

Có thể bạn quan tâm:

Preview text:

19112023 - CLINICAL TRIALS
1. Which phase includes participants with the disease the product could treat potentially? A. Phase 1 B. Phase 2 C. Phase 3 D. Phase 4
2. Which factor below decides most the success of a clinical trial? A. Laboratory B. Finance C. Length D. Volunteers’ participation
3. Which of these is NOT a function of FDA?
A. Creating guidelines for the approval & use of drugs.
B. Requiring that all approved drugs fulfill 2 standards.
C. Be responsible for the safety regulation of most types of drugs.
D. Testing drugs through 4 phases of clinical trials before they can be sold to individuals.
4. How long is the pre-clinical development stage? A. 1 year B. 1-2 years C. 3-4 years D. 4-5 years
5. Which statement is INCORRECT?
A. Only 1 or 2 medicines gets approval for use on prescription.
B. Lisinopril treats hypertension.
C. Phase 3 is the longest of the 3 phases.
D. All medicines used today must undergo chemical processes.
6. Which phase finds the most suitable dose? A. Phase 1 B. Phase 2 C. Phase 3 D. Phase 4 7. There is a
trend for in vitro and human volunteer protocols animal tests where possible.
A. continuing – tested - to replace
C. continuing – testing - to be replaced
B. to continuing – testing - to replace
D. continuing – testing - to replace
8. Which phase includes participants with the disease the product could treat potentially? A. Phase 1 B. Phase 2 C. Phase 3 D. Phase 4
9. Which factor below decides most the success of a clinical trial? A. Laboratory B. Finance C. Length D. Volunteers’ participation
10. Which of these is NOT a function of FDA?
A. Creating guidelines for the approval & use of drugs.
B. Requiring that all approved drugs fulfill 2 standards.
C. Be responsible for the safety regulation of most types of drugs.
D. Testing drugs through 4 phases of clinical trials before they can be sold to individuals. 1
11. Which definition below refers to “placebo”? A. With active ingredients B. With inactive ingredients
C. With inactive ingredients w treatment value
D. With inactive ingredients, no medicinal value 12. Which information is IN CORRECT about blinding feature?
A. The identification related to participants will be revealed at the end of the trial.
B. Single-blinding means participants know well about the treatment they are receiving.
C. Thanks to blinding, bias does not affect the trial or the interpretation of its results.
D. A double-blinded trial means that neither the team nor the participants know each other well.
13. Clinical trials are generally not a __________ for patients to receive long-term treatment for their
chronic disease still clinical trials often represent an option to be seriously __________.
A. means/ take into consideration B. means/ considered C. means/ into considering
D. mean/ taken into consideration
14. Which information below is INCORRECT?
A. Drugs are tested before going on market.
B. Drugs are tested on animals first and later on humans.
C. Participants do not know which treatment they are treating.
D. It takes a small amount of money and lots of time to have one clinical trial.
15. The participants found __________ – and who agree __________ – are given specific instructions,
and then monitor and carefully __________ during the trial and after it is completed.
A. eligible/ to participate/ assessed
B. eligibly/ to participate/ assessed
C. eligible/ participate/ assessing
D. eligibly/ participate/ assessing 2 3